February 25, 2014

DSN recently caught up with Dick Domann, VP pharmacy services for TrialCard, to talk about adherence and abandonment solutions. Capturing otherwise lost scripts is a significant opportunity for retail pharmacy, and TrialCard has a tool to help reclaim those prescriptions.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

August 27, 2013

How can retail pharmacy play a greater role in battling the nation's prescription drug abuse epidemic? Data. To shed light on how CVS Caremark tapped its extensive prescribing database to identify signs of potential inappropriate prescribing, CVS Caremark¹s Troy Brennan talked with DSN about the program and the ongoing efforts to combat prescription drug abuse.

August 20, 2013

A pair of pharmacists from Whitsett, N.C., were the winners of a special text-to-vote competition to highlight independent pharmacy best practices at the Cardinal Health 2013 Retail Business Conference.

August 5, 2013

Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.

July 10, 2013

DSN had the opportunity to speak with Christian Tadrus, who has been the pharmacist at Sam’s Health Mart in the Colombia, Mo. area, since 1997. Tadrus, a member of McKesson’s Sponsored Clinical Services pharmacy network, participates in a number of adherence support programs, including the award-winning Pharmacy Intervention adherence coaching program, StudyLink patient recruitment for clinical trials program, and the RxRapid Response pharmacist survey program.

May 6, 2013

There is no substitute for the face-to-face counsel of the pharmacist in improving patient adherence — and he’s got the data to prove it. That’s the message Thrifty White president and CEO Bob Narveson had for DSNTV in part two of a frank and broad-ranging interview about the state of the industry, the role community pharmacy can play in healthcare reform and the results of an exciting new study that validates the role companies like his can play to innovate patient care, improve outcomes and lower healthcare costs.

April 12, 2013

Westport VP and general manager Paul Hemings spoke with DSN about the company's introduction of Zephrex-D, a meth-resistant pseudoephedrine product, to market. Beyond taking a bite out of the $23.5 billion methamphetamine trade, Hemings discussed the benefits of having Zephrex-D behind the pharmacy counter.

April 2, 2013

DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals' Zephrex-D, a pseudoephedrine product with a unique point of differentiation.

July 11, 2012

DSN talked to Cardinal Health SVP independent sales Steve Lawrence about the big news from Cardinal’s 2012 Retail Business Conference, including a best practices competition for its customers, its Women in Pharmacy program and Cardinal’s joint outreach program with the Ohio State University College of Pharmacy aimed at preventing prescription drug abuse.

July 2, 2015

Pharmacy same-store sales a big driver behind June results at Rite Aid. 

July 1, 2015

New exchange plan enrollees spent less on medications in the first quarter of 2015 compared with the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report released on Wednesday.

July 1, 2015

An analysis of five pharmacy case studies conducted for the National Community Pharmacists Association has found that medication synchronization brings positive results to community pharmacy.

July 1, 2015

Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.

June 30, 2015

The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics. 

June 30, 2015

The Food and Drug Administration on Tuesday issued guidance indicating that the agency would give pharmacies  an additional four months to comply with product tracing requirements scheduled to take effect July 1, 2015.

June 29, 2015

Tris Pharma will supply the new Robitussin long-acting dextromethorphan. 

June 26, 2015

As McKesson ideaShare 2015 was just getting underway, DSN editor-in-chief Rob Eder caught up with McKesson president of U.S. Pharmaceutical Mark Walchirk about the state of the pharmacy business, how smart independent pharmacy owners are finding new ways to compete and what McKesson is doing to help independent pharmacies become more broadly integrated into the patient care team, drive improved outcomes and improve profitability.

June 25, 2015

McKesson ideaShare 2015 kicked off Wednesday with a full day of continuing education sessions to help independent pharmacists remain at the cutting edge of patient care and pharmacy practice. Over the course of the four-day conference, McKesson will host more than 30 CE sessions, covering such important topics as medication synchronization, marketing in a digital world, building prescriber relationships and much more.

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 24, 2015

Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.

June 23, 2015

The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance. 

June 23, 2015

Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength. 

June 22, 2015

Acura Pharmaceuticals and Bayer Healthcare are partnering to develop a product with pseudoephedrine that would be resistant to being used in methamphetamine.